S&P 500   4,298.30 (-0.03%)
DOW   33,563.55 (-0.31%)
QQQ   360.05 (+0.57%)
AAPL   171.70 (+0.59%)
MSFT   317.94 (+1.37%)
META   304.76 (+0.26%)
GOOGL   131.87 (-0.33%)
AMZN   127.76 (+1.41%)
TSLA   251.87 (+2.23%)
NVDA   436.98 (+1.41%)
NIO   9.04 (+1.46%)
BABA   87.04 (+1.75%)
AMD   104.07 (+1.27%)
T   15.00 (-0.07%)
F   12.54 (-0.16%)
MU   68.05 (+4.37%)
CGC   0.80 (-1.19%)
GE   110.46 (-1.67%)
DIS   80.89 (+0.95%)
AMC   8.06 (+3.47%)
PFE   33.02 (+2.90%)
PYPL   58.63 (+0.77%)
NFLX   377.72 (+0.36%)
S&P 500   4,298.30 (-0.03%)
DOW   33,563.55 (-0.31%)
QQQ   360.05 (+0.57%)
AAPL   171.70 (+0.59%)
MSFT   317.94 (+1.37%)
META   304.76 (+0.26%)
GOOGL   131.87 (-0.33%)
AMZN   127.76 (+1.41%)
TSLA   251.87 (+2.23%)
NVDA   436.98 (+1.41%)
NIO   9.04 (+1.46%)
BABA   87.04 (+1.75%)
AMD   104.07 (+1.27%)
T   15.00 (-0.07%)
F   12.54 (-0.16%)
MU   68.05 (+4.37%)
CGC   0.80 (-1.19%)
GE   110.46 (-1.67%)
DIS   80.89 (+0.95%)
AMC   8.06 (+3.47%)
PFE   33.02 (+2.90%)
PYPL   58.63 (+0.77%)
NFLX   377.72 (+0.36%)
S&P 500   4,298.30 (-0.03%)
DOW   33,563.55 (-0.31%)
QQQ   360.05 (+0.57%)
AAPL   171.70 (+0.59%)
MSFT   317.94 (+1.37%)
META   304.76 (+0.26%)
GOOGL   131.87 (-0.33%)
AMZN   127.76 (+1.41%)
TSLA   251.87 (+2.23%)
NVDA   436.98 (+1.41%)
NIO   9.04 (+1.46%)
BABA   87.04 (+1.75%)
AMD   104.07 (+1.27%)
T   15.00 (-0.07%)
F   12.54 (-0.16%)
MU   68.05 (+4.37%)
CGC   0.80 (-1.19%)
GE   110.46 (-1.67%)
DIS   80.89 (+0.95%)
AMC   8.06 (+3.47%)
PFE   33.02 (+2.90%)
PYPL   58.63 (+0.77%)
NFLX   377.72 (+0.36%)
S&P 500   4,298.30 (-0.03%)
DOW   33,563.55 (-0.31%)
QQQ   360.05 (+0.57%)
AAPL   171.70 (+0.59%)
MSFT   317.94 (+1.37%)
META   304.76 (+0.26%)
GOOGL   131.87 (-0.33%)
AMZN   127.76 (+1.41%)
TSLA   251.87 (+2.23%)
NVDA   436.98 (+1.41%)
NIO   9.04 (+1.46%)
BABA   87.04 (+1.75%)
AMD   104.07 (+1.27%)
T   15.00 (-0.07%)
F   12.54 (-0.16%)
MU   68.05 (+4.37%)
CGC   0.80 (-1.19%)
GE   110.46 (-1.67%)
DIS   80.89 (+0.95%)
AMC   8.06 (+3.47%)
PFE   33.02 (+2.90%)
PYPL   58.63 (+0.77%)
NFLX   377.72 (+0.36%)

RenaissanceRe (RNR) Stock Forecast, Price & News

$200.93
-2.80 (-1.37%)
(As of 12:39 PM ET)
Compare
Today's Range
$200.31
$204.09
50-Day Range
$177.07
$205.89
52-Week Range
$128.00
$223.80
Volume
105,402 shs
Average Volume
405,690 shs
Market Capitalization
$10.28 billion
P/E Ratio
25.12
Dividend Yield
0.76%
Price Target
$230.71

RenaissanceRe MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.57 Rating Score
Upside/​Downside
13.2% Upside
$230.71 Price Target
Short Interest
Healthy
1.55% of Shares Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.91
Upright™ Environmental Score
News Sentiment
1.64mentions of RenaissanceRe in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
4.78%
From $26.80 to $28.08 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.42 out of 5 stars

Finance Sector

440th out of 871 stocks

Fire, Marine, & Casualty Insurance Industry

22nd out of 48 stocks


RNR stock logo

About RenaissanceRe (NYSE:RNR) Stock

RenaissanceRe Holdings Ltd. provides reinsurance and insurance products around the world. The company was founded in 1993 and is headquartered in Bermuda with offices in Ireland, Australia, Switzerland, Singapore, and the US.

The company operates through two segments that include multiple underlying businesses and investment vehicles. The two main segments are Property and Casualty & Specialty.  The company operates through intermediaries that include DaVinci Resinsurance Inc, Top Layer Reinsurance LTD, and RennaisanceRe Syndicate 1458 among others.

Top Layer Re is the first major venture and was started in 1999. It is a joint venture with State Farm targeting high layers of the US reinsurance business. DaVinci Re was formed in the wake of 9/11 to assist with capacity and it was given added capacity in the wake of hurricanes Katrina, Rita, and Wilma. Medici was formed in 2009 and is an open-ended fund intended to spur investment in the catastrophe bond market.

The Property segment writes catastrophic insurance policies to insure insurance and reinsurance companies against natural and man-made catastrophes. These include but are not limited to hurricanes, floods, freezes, and terrorism.

The Casualty & Specialty segment provides a wide range of consumer products including business insurance, malpractice insurance, liability insurance, workers' compensation, mortgage insurance, and health insurance among others.

Among RenaissanceRe’s Specialty businesses is capital management. The firm offers 6 investment vehicles and has more than $11 billion under management making it the #1 ILS or insurance-linked asset manager in the US. In regards to its credit ratings, the firm and all of its vehicles carry an A or better rating from every credit rating agency.

 

RNR Price History

RNR Stock News Headlines

Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
The Latest Analyst Ratings for RenaissanceRe Holdings
Renaissancere (RNR) Earnings Dates & Reports
RenaissanceRe: Q2 Earnings Snapshot
RenaissanceRe Holdings's Earnings Outlook
RenaissanceRe appoints permanent chief risk officer
See More Headlines
Receive RNR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RenaissanceRe and its competitors with MarketBeat's FREE daily newsletter.

RNR Company Calendar

Last Earnings
7/25/2023
Ex-Dividend for 9/29 Dividend
9/14/2023
Today
9/29/2023
Dividend Payable
9/29/2023
Next Earnings (Estimated)
11/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Fire, marine, & casualty insurance
Sub-Industry
Reinsurance
Sector
Finance
CUSIP
G7496G10
Employees
718
Year Founded
1993

Price Target and Rating

Average Stock Price Forecast
$230.71
High Stock Price Forecast
$266.00
Low Stock Price Forecast
$175.00
Forecasted Upside/Downside
+13.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
7 Analysts

Profitability

Net Income
$-1,061,200,000.00
Pretax Margin
10.34%

Debt

Sales & Book Value

Annual Sales
$5.06 billion
Cash Flow
$7.54 per share
Book Value
$104.69 per share

Miscellaneous

Free Float
50,517,000
Market Cap
$10.43 billion
Optionable
Optionable
Beta
0.42

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Kevin Joseph O'Donnell (Age 56)
    Pres, CEO & Director
    Comp: $5.12M
  • Mr. Robert QutubMr. Robert Qutub (Age 61)
    Exec. VP & CFO
    Comp: $2.36M
  • Mr. Sean G. Brosnan C.F.A.Mr. Sean G. Brosnan C.F.A. (Age 47)
    Chief Investment Officer & Sr. VP
    Comp: $1.36M
  • Mr. Ross Arthur Curtis (Age 50)
    Exec. VP & Chief Portfolio Officer
    Comp: $2.15M
  • Mr. James Christopher Fraser (Age 47)
    Chief Accounting Officer & Sr. VP
  • Mr. Blythe Walker
    Sr. VP & CTO
  • Mr. Keith Alfred McCue
    Sr. VP of Fin. & Investor Relations
  • Ms. Shannon Lowry Bender (Age 56)
    Exec. VP, Group Gen. Counsel & Corp. Sec.
  • Ms. Keil Gunther (Age 50)
    Sr. VP, Head of Global Marketing & Client Communications
  • Becket McNab
    Chief HR Officer













RNR Stock - Frequently Asked Questions

Should I buy or sell RenaissanceRe stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RenaissanceRe in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" RNR shares.
View RNR analyst ratings
or view top-rated stocks.

What is RenaissanceRe's stock price forecast for 2023?

7 brokers have issued 12 month target prices for RenaissanceRe's shares. Their RNR share price forecasts range from $175.00 to $266.00. On average, they anticipate the company's stock price to reach $230.71 in the next year. This suggests a possible upside of 13.2% from the stock's current price.
View analysts price targets for RNR
or view top-rated stocks among Wall Street analysts.

How have RNR shares performed in 2023?

RenaissanceRe's stock was trading at $184.23 at the beginning of the year. Since then, RNR shares have increased by 10.6% and is now trading at $203.73.
View the best growth stocks for 2023 here
.

When is RenaissanceRe's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our RNR earnings forecast
.

How were RenaissanceRe's earnings last quarter?

RenaissanceRe Holdings Ltd. (NYSE:RNR) posted its quarterly earnings results on Tuesday, July, 25th. The insurance provider reported $8.79 EPS for the quarter, beating the consensus estimate of $7.58 by $1.21. The insurance provider had revenue of $2.20 billion for the quarter, compared to analysts' expectations of $1.96 billion. RenaissanceRe had a net margin of 5.60% and a trailing twelve-month return on equity of 14.22%. The firm's quarterly revenue was up 17.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $5.51 earnings per share.

How often does RenaissanceRe pay dividends? What is the dividend yield for RenaissanceRe?

RenaissanceRe announced a quarterly dividend on Wednesday, August 2nd. Stockholders of record on Friday, September 15th will be given a dividend of $0.38 per share on Friday, September 29th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date of this dividend is Thursday, September 14th.
Read our dividend analysis for RNR
.

Is RenaissanceRe a good dividend stock?

RenaissanceRe (NYSE:RNR) pays an annual dividend of $1.52 per share and currently has a dividend yield of 0.76%. The company has been increasing its dividend for 28 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 19.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, RNR will have a dividend payout ratio of 5.41% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for RNR.

What is Neill A. Currie's approval rating as RenaissanceRe's CEO?

6 employees have rated RenaissanceRe Chief Executive Officer Neill A. Currie on Glassdoor.com. Neill A. Currie has an approval rating of 100% among the company's employees. This puts Neill A. Currie in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of RenaissanceRe own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RenaissanceRe investors own include Advanced Micro Devices (AMD), Xilinx (XLNX), Exxon Mobil (XOM), Home Depot (HD), Verizon Communications (VZ), Bank of America (BAC), Keysight Technologies (KEYS), NVIDIA (NVDA), Fortinet (FTNT) and Intel (INTC).

What is RenaissanceRe's stock symbol?

RenaissanceRe trades on the New York Stock Exchange (NYSE) under the ticker symbol "RNR."

How do I buy shares of RenaissanceRe?

Shares of RNR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is RenaissanceRe's stock price today?

One share of RNR stock can currently be purchased for approximately $203.73.

How much money does RenaissanceRe make?

RenaissanceRe (NYSE:RNR) has a market capitalization of $10.43 billion and generates $5.06 billion in revenue each year. The insurance provider earns $-1,061,200,000.00 in net income (profit) each year or $8.00 on an earnings per share basis.

How many employees does RenaissanceRe have?

The company employs 718 workers across the globe.

How can I contact RenaissanceRe?

RenaissanceRe's mailing address is RENAISSANCE HOUSE 12 CROW LANE, PEMBROKE D0, HM 19. The official website for the company is www.renre.com. The insurance provider can be reached via phone at (441) 295-4513, via email at investorrelations@renre.com, or via fax at 441-292-9453.

This page (NYSE:RNR) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -